ALK Positive/LUNGevity Foundation 2020 RFA
קרן | LUNGevity |
---|---|
מדינה | U.S.A. |
סוג | Research Grants |
תאריך אחרון | 12/03/2020 |
פקולטה | Life Sciences, Medicine |
תיאור |
The goal of the program is to fund high-impact research that seeks to transform the future for patients affected by ALK-positive non-small cell lung cancer by transforming ALK-positive lung cancer into a chronic or curable condition.
PI must be from a US institution. International co-applicants are welcome.
Funding: $500,000 total
Duration: 2 years
Research Authority due date: 7.2.20
LOI (required) due date: 12.3.20
Full proposal due date: 18.6.20
|
קבצים מצורפים | |
קישור | לאתר |
עדכון אחרון | עדכון אחרון: 15/01/2020 |